Luc Buee

DIRECTEUR DE RECHERCHE EPST - Neurosciences
luc_buee.JPG

Luc Buee

DIRECTEUR DE RECHERCHE EPST - Neurosciences

Publications

Article dans des revues

  • Ouada Nebie, Lassina Barro, Yu-Wen Wu, Folke Knutson, Luc Buee, et al.. Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro. Platelets, Taylor & Francis, 2020, pp.1-12. ⟨10.1080/09537104.2020.1732324⟩. ⟨hal-02541231⟩
  • Ouada Nebie, Lassina Barro, Yu-Wen Wu, Folke Knutson, Luc Buee, et al.. Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro. Platelets, Taylor & Francis, 2020, 1, pp.1-12. ⟨10.1080/09537104.2020.1732324⟩. ⟨hal-02541219⟩
  • Annerieke Sierksma, Ashley Lu, Renzo Mancuso, Nicola Fattorelli, Nicola Thrupp, et al.. Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology. EMBO Molecular Medicine, Wiley Open Access, 2020, pp.e10606. ⟨10.15252/emmm.201910606⟩. ⟨inserm-02450349⟩
  • Mégane Homa, Anne Loyens, Sabiha Eddarkaoui, Emilie Faivre, Vincent Deramecourt, et al.. The TMEM240 Protein, Mutated in SCA21, Is Expressed in Purkinje Cells and Synaptic Terminals. The Cerebellum, Taylor & Francis Ltd., In press, Ahead of print. ⟨10.1007/s12311-020-01112-y⟩. ⟨inserm-02463227⟩
  • Yann Fichou, Youssra Al-Hilaly, François Devred, Caroline Smet-Nocca, Philipp Tsvetkov, et al.. The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2019, 7 (1), ⟨10.1186/s40478-019-0682-x⟩. ⟨hal-02055894⟩
  • Enrico Faldini, Tariq Ahmed, Luc Buée, David Blum, Detlef Balschun. Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2019, 7 (1), pp.202. ⟨10.1186/s40478-019-0813-4⟩. ⟨hal-02413632⟩
  • Charlotte Gary, Suzanne Lam, Anne-Sophie Herard, James Koch, Fanny Petit, et al.. Encephalopathy induced by Alzheimer brain inoculation in a non-human primate. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2019, 7 (1), ⟨10.1186/s40478-019-0771-x⟩. ⟨hal-02391937⟩
  • Ouada Nebie, David Devos, Valérie Vingtdeux, Lassina Barro, Jean-Christophe Devedjian, et al.. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. Journal of Biomedical Science, BioMed Central, 2019, 26 (1), pp.89. ⟨10.1186/s12929-019-0579-9⟩. ⟨inserm-02350063⟩
  • Morvane Colin, Simon Dujardin, Susanna Schraen-Maschke, Guy Meno-Tetang, Charles Duyckaerts, et al.. From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy. Acta Neuropathologica, Springer Verlag, 2019, Epub ahead of print. ⟨10.1007/s00401-019-02087-9⟩. ⟨inserm-02348330⟩
  • Christina Ising, Carmen Venegas, Shuangshuang Zhang, Hannah Scheiblich, Susanne Schmidt, et al.. NLRP3 inflammasome activation drives tau pathology. Nature, Nature Publishing Group, 2019, 575 (7784), pp.669-673. ⟨10.1038/s41586-019-1769-z⟩. ⟨hal-02413609⟩
  • Kevin Carvalho, Emilie Faivre, Marie Pietrowski, Xavier Marques, Victoria Gomez-Murcia, et al.. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. Brain - A Journal of Neurology , Oxford University Press (OUP), 2019, 142 (11), pp.3636-3654. ⟨10.1093/brain/awz288⟩. ⟨inserm-02350065⟩
  • Ouada Nebie, David Devos, Valérie Vingtdeux, Lassina Barro, Jean-Christophe Devedjian, et al.. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. Journal of Biomedical Science, BioMed Central, 2019, 26 (1), pp.89. ⟨10.1186/s12929-019-0579-9⟩. ⟨inserm-02348443⟩
  • Stefania Zappettini, Emilie Faivre, Antoine Ghestem, Sébastien Carrier, Luc Buee, et al.. Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy. Frontiers in Cellular Neuroscience, Frontiers, 2019, 13, pp.438. ⟨10.3389/fncel.2019.00438⟩. ⟨inserm-02348452⟩
  • Stefania Zappettini, Emilie Faivre, Antoine Ghestem, Sébastien Carrier, Luc Buee, et al.. Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy. Frontiers in Cellular Neuroscience, Frontiers, 2019, 13, pp.438. ⟨10.3389/fncel.2019.00438⟩. ⟨inserm-02350061⟩
  • Vincent Huin, Claire-Marie Dhaenens, Mégane Homa, Kévin Carvalho, Luc Buée, et al.. Neurogenetics of the Human Adenosine Receptor Genes: Genetic Structures and Involvement in Brain Diseases. Journal of Caffeine and Adenosine Research, New Rochelle, N.Y. : Mary Ann Liebert, Inc., [2018]-, 2019, 9 (3), pp.73-88. ⟨10.1089/caff.2019.0011⟩. ⟨inserm-02460598⟩
  • Nicolas Sergeant, Valérie Vingtdeux, Sabiha Eddarkaoui, Marion Gay, Caroline Evrard, et al.. New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease. Neurobiology of Disease, Elsevier, 2019, 129, pp.217-233. ⟨10.1016/j.nbd.2019.03.028⟩. ⟨inserm-02350071⟩
  • Elian Dupré, Clément Danis, Alexis Arrial, Xavier Hanoulle, Mégane Homa, et al.. Single Domain Antibody Fragments as New Tools for the Detection of Neuronal Tau Protein in Cells and in Mice Studies. ACS Chemical Neuroscience, American Chemical Society (ACS), 2019, 10 (9), pp.3997-4006. ⟨10.1021/acschemneuro.9b00217⟩. ⟨hal-02337161⟩
  • Isabel Paiva, Kévin Carvalho, Patricia Santos, Lucrezia Cellai, Maria Angeliki S. Pavlou, et al.. A2A R‐induced transcriptional deregulation in astrocytes: An in vitro study. Glia, Wiley, 2019, 67 (12), pp.2329-2342. ⟨10.1002/glia.23688⟩. ⟨inserm-02350068⟩
  • Marie Albert, Georges Mairet-Coello, Clément Danis, Sarah Lieger, Raphaëlle Caillierez, et al.. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody. Brain - A Journal of Neurology , Oxford University Press (OUP), 2019, 142 (6), pp.1736-1750. ⟨10.1093/brain/awz100⟩. ⟨inserm-02348408⟩
  • Antoine Leboucher, Tariq Ahmed, Emilie Caron, Anne Tailleux, Sylvie Raison, et al.. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model. Neurobiology of Disease, Elsevier, 2019, 125, pp.14-22. ⟨10.1016/j.nbd.2019.01.008⟩. ⟨inserm-02350072⟩
  • Manon Domise, Florent Sauvé, Sébastien Didier, Raphaëlle Caillerez, Séverine Bégard, et al.. Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process. Cell Death and Disease, Nature Publishing Group, 2019, 10 (3), pp.221. ⟨10.1038/s41419-019-1464-x⟩. ⟨inserm-02348480⟩
  • Amulya Nidhi Shrivastava, Virginie Redeker, Laura Pieri, Luc Bousset, Marianne Renner, et al.. Clustering of Tau fibrils impairs the synaptic composition of α3‐Na + /K + ‐ ATP ase and AMPA receptors. EMBO Journal, EMBO Press, 2019, 38 (3), pp.e99871. ⟨10.15252/embj.201899871⟩. ⟨cea-02279806⟩
  • Annerieke Sierksma, Ashley Lu, Evgenia Salta, Elke Vanden Eynden, Zsuzsanna Callaerts-Vegh, et al.. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Molecular Neurodegeneration, BioMed Central, 2018, 13 (1), pp.54. ⟨10.1186/s13024-018-0285-1⟩. ⟨inserm-02350076⟩
  • Annerieke Sierksma, Ashley Lu, Evgenia Salta, Elke Vanden Eynden, Zsuzsanna Callaerts-Vegh, et al.. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Molecular Neurodegeneration, BioMed Central, 2018, 13 (1), pp.54. ⟨10.1186/s13024-018-0285-1⟩. ⟨inserm-01930483⟩
  • Snehajyoti Chatterjee, Raphaelle Cassel, Anne Schneider‐anthony, Karine Mérienne, Brigitte Cosquer, et al.. Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. EMBO Molecular Medicine, Wiley Open Access, 2018, 10 (11), pp.e8587. ⟨10.15252/emmm.201708587⟩. ⟨hal-02106506⟩
  • Snehajyoti Chatterjee, Raphaelle Cassel, Anne Schneider‐anthony, Karine Mérienne, Brigitte Cosquer, et al.. Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. EMBO Molecular Medicine, Wiley Open Access, 2018, 10 (11), pp.e8587. ⟨10.15252/emmm.201708587⟩. ⟨inserm-01930486⟩
  • Aurélie Joly-Amado, Maud Gratuze, Hamza Benderradji, Didier Vieau, Luc Buee, et al.. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies]. médecine/sciences, EDP Sciences, 2018, 34 (11), pp.929-935. ⟨10.1051/medsci/2018238⟩. ⟨inserm-02350074⟩
  • Aurélie Joly-Amado, Maud Gratuze, Hamza Benderradji, Didier Vieau, Luc Buée, et al.. Relation mutuelle entre Tau et signalisation centrale de l’insuline. médecine/sciences, EDP Sciences, 2018, 34 (11), pp.929-935. ⟨10.1051/medsci/2018238⟩. ⟨inserm-01958478⟩
  • Aurélie Joly-Amado, Maud Gratuze, Hamza Benderradji, Didier Vieau, Luc Buée, et al.. Relation mutuelle entre Tau et signalisation centrale de l’insuline. médecine/sciences, EDP Sciences, 2018, 34 (11), pp.929-935. ⟨10.1051/medsci/2018238⟩. ⟨inserm-02061458⟩
  • Houda Benhelli-Mokrani, Zeyni Mansuroglu, Alban Chauderlier, Benoit Albaud, David Gentien, et al.. Genome-wide identification of genic and intergenic neuronal DNA regions bound by Tau protein under physiological and stress conditions. Nucleic Acids Research, Oxford University Press, 2018, ⟨10.1093/nar/gky929⟩. ⟨hal-02404215⟩
  • Luc Cellai, Kevin Carvalho, Emilie Faivre, Aude Deleau, Didier Vieau, et al.. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease. Frontiers in Neuroscience, Frontiers, 2018, 12, pp.520. ⟨10.3389/fnins.2018.00520⟩. ⟨inserm-01930487⟩
  • Lucrezia Cellai, Kevin Carvalho, Emilie Faivre, Aude Deleau, Didier Vieau, et al.. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease. Frontiers in Neuroscience, Frontiers, 2018, 12, pp.520. ⟨10.3389/fnins.2018.00520⟩. ⟨inserm-02350079⟩
  • Alban Chauderlier, Melissa Gilles, Andrea Spolcova, Raphaëlle Caillierez, Maggy Chwastyniak, et al.. Tau/DDX6 interaction increases microRNA activity. Biochimica et Biophysica Acta - Gene Regulatory Mechanisms , Elsevier, 2018, 1861 (8), pp.762-772. ⟨10.1016/j.bbagrm.2018.06.006⟩. ⟨hal-02251328⟩
  • Mariana Ferreira, Diana Ferreira, Vânia Batalha, Inês Marques-Morgado, Joana Coelho, et al.. Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry, Nature Publishing Group, 2018, ⟨10.1038/s41380-018-0110-9⟩. ⟨inserm-01833281⟩
  • Emilie Faivre, Joana Coelho, Katja Zornbach, Enas Malik, Younis Baqi, et al.. Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease. Frontiers in Molecular Neuroscience, Frontiers Media, 2018, 11, pp.235. ⟨10.3389/fnmol.2018.00235⟩. ⟨inserm-01930489⟩
  • Olivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, Stéphanie Bombois, Bernadette Allinquant, et al.. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers. Alzheimer's and Dementia, Elsevier, 2018, 14 (7), pp.858 - 868. ⟨10.1016/j.jalz.2018.01.004⟩. ⟨hal-01842225⟩
  • Olivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, Stéphanie Bombois, Bernadette Allinquant, et al.. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Elsevier, 2018, 14 (7), pp.858-868. ⟨10.1016/j.jalz.2018.01.004⟩. ⟨hal-02533144⟩
  • David Blum, Yijuang Chern, Maria Rosaria Domenici, Luc Buée, Chien-Yu Lin, et al.. The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease. Journal of Caffeine and Adenosine Research, New Rochelle, N.Y. : Mary Ann Liebert, Inc., [2018]-, 2018, 8 (2), pp.43 - 58. ⟨10.1089/caff.2018.0006⟩. ⟨inserm-01930490⟩
  • Olivier Vercruysse, Claire Paquet, Eloi Gabelle, Xavier Delbeuck, Frédéric Blanc, et al.. Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers. Current Alzheimer Research, Bentham Science Publishers, 2018, 15 (7), pp.691 - 700. ⟨10.2174/1567205015666180110113238⟩. ⟨hal-01842197⟩
  • Marion Gay, Pascal Carato, Mathilde Coevoet, Nicolas Renault, Paul-Emmanuel Larchanché, et al.. New phenylaniline derivatives as modulators of amyloid protein precursor metabolism. Bioorganic and Medicinal Chemistry, Elsevier, 2018, 26 (8), pp.2151-2164. ⟨10.1016/j.bmc.2018.03.016⟩. ⟨hal-02060708⟩
  • Chia-Chia Lee, Ching-Pang Chang, Chun-Jung Lin, Hsing-Lin Lai, Yu-Han Kao, et al.. Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease. Molecular Neurobiology, Humana Press, 2018, ⟨10.1007/s12035-018-1030-z⟩. ⟨inserm-01833298⟩
  • Cyril Laurent, Luc Buée, David Blum. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?. Biomedical journal, Elsevier, 2018, 41 (1), pp.21 - 33. ⟨10.1016/j.bj.2018.01.003⟩. ⟨inserm-01833293⟩
  • Maud Gratuze, Aurélie Joly-Amado, Didier Vieau, Luc Buée, David Blum. Mutual relationship between Tau and central insulin signalling: consequences for AD and Tauopathies ?. Neuroendocrinology, Karger, 2018, ⟨10.1159/000487641⟩. ⟨inserm-01833302⟩
  • Marie D’orange, Gwenaëlle Auregan, Dimitri Cheramy, Mylène Gaudin-Guérif, Sarah Lieger, et al.. Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat. Brain - A Journal of Neurology , Oxford University Press (OUP), 2018, 141 (2), pp.535-549. ⟨10.1093/brain/awx342⟩. ⟨cea-02074052⟩
  • Marion Gay, Caroline Evrard, Florian Descamps, Pascal Carato, Nicolas Renault, et al.. A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect β-secretase inhibitors. European Journal of Medicinal Chemistry, Elsevier, 2018, 159, pp.104-125. ⟨10.1016/j.ejmech.2018.08.092⟩. ⟨hal-02060447⟩
  • Anna Susloparova, Yannick Coffinier, Fabien Alibart, Vincent Thomy, Steve Arscott, et al.. Fabrication of new transparent MEAs made from pure PEDOT:PSS and their optical/electrical properties for neurons' activity assessment in the frame of Alzheimer disease case study. Frontiers in Cellular Neuroscience, Frontiers, 2018, 12, ⟨10.3389/conf.fncel.2018.38.00035⟩. ⟨hal-02350962⟩
  • Caroline Evrard, Pascal Kieulen-Campard, Mathilde Coevoet, Rémi Opsomer, Bernadette Tasiaux, et al.. Contribution of the Endosomal-Lysosomal and Proteasomal Systems in Amyloid-β Precursor Protein Derived Fragments Processing. Frontiers in Cellular Neuroscience, Frontiers, 2018, 12, pp.435. ⟨10.3389/fncel.2018.00435⟩. ⟨hal-02060617⟩
  • Emmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, Audrey Gabelle, Sylvain Lehmann, et al.. Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ1–42 and Tau Proteins in Elderly Patients With Mild Cognitive Impairment. Frontiers in Aging Neuroscience, Frontiers, 2018, 10, pp.297. ⟨10.3389/fnagi.2018.00297⟩. ⟨hal-02313963⟩
  • Ioannis Sotiropoulos, Marie-Christine Galas, Joana Silva, Efthimios Skoulakis, Susanne Wegmann, et al.. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2017, 5 (1), ⟨10.1186/s40478-017-0489-6⟩. ⟨inserm-01833336⟩
  • Vincent Huin, Luc Buée, Hélène Behal, Julien Labreuche, Bernard Sablonnière, et al.. Alternative promoter usage generates novel shorter MAPT mRNA transcripts in Alzheimer’s disease and progressive supranuclear palsy brains. Scientific Reports, Nature Publishing Group, 2017, 7 (1), pp.12589. ⟨10.1038/s41598-017-12955-7⟩. ⟨inserm-02460428⟩
  • Cyril Laurent, Guillaume Dorothée, Stéphane Hunot, Elodie Martin, Cecile Delarasse, et al.. Tau et troubles cognitifs. médecine/sciences, EDP Sciences, 2017, 33 (10), pp.817-819. ⟨10.1051/medsci/20173310002⟩. ⟨hal-02541223⟩
  • Cyril Laurent, Guillaume Dorothee, Stéphane Hunot, Elodie Martin, Cecile Delarasse, et al.. Tau et troubles cognitifs. médecine/sciences, EDP Sciences, 2017, 33 (10), pp.817 - 819. ⟨10.1051/medsci/20173310002⟩. ⟨inserm-01833339⟩
  • Elodie Marciniak, Antoine Leboucher, Emilie Caron, Tariq Ahmed, Anne Tailleux, et al.. Tau deletion promotes brain insulin resistance. Journal of Experimental Medicine, Rockefeller University Press, 2017, 214 (8), pp.2257 - 2269. ⟨10.1084/jem.20161731⟩. ⟨inserm-01833342⟩
  • Fanny Jumeau, Frédéric Chalmel, Francisco-Jose Fernandez-Gomez, Celine Carpentier, Hélène Obriot, et al.. Defining the human sperm microtubulome: an integrated genomics approach. Biology of Reproduction, Society for the Study of Reproduction, 2017, 96 (1), pp.93-106. ⟨10.1095/biolreprod.116.143479⟩. ⟨hal-01515563⟩
  • Cyril Laurent, Guillaume Dorothee, Stéphane Hunot, Elodie Martin, Yann Monnet, et al.. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain - A Journal of Neurology , Oxford University Press (OUP), 2016, 140 (1), pp.184 - 200. ⟨10.1093/brain/aww270⟩. ⟨inserm-01833350⟩
  • Wesley Chen, Edsel Abud, Stephen Yeung, Anita Lakatos, Trevor Nassi, et al.. Increased tauopathy drives microglia-mediated clearance of beta-amyloid. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2016, 4 (1), ⟨10.1186/s40478-016-0336-1⟩. ⟨inserm-01833353⟩
  • Ioannis Sotiropoulos, Marie-Christine Galas, Joana M. Silva, Efthimios Skoulakis, Susanne Wegmann, et al.. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2016, 5 (1), pp.91. ⟨10.1186/s40478-017-0489-6⟩. ⟨inserm-01654098⟩
  • Amrit Mudher, Jean-Pierre Brion, Jesus Avila, Miguel Medina, Luc Buée. EuroTau: towing scientists to tau without tautology. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2016, 5 (1), pp.90. ⟨10.1186/s40478-017-0491-z⟩. ⟨inserm-01654097⟩
  • Véronique Paban, Béatrice Loriod, Claude Villard, Luc Buee, David Blum, et al.. Omics analysis of mouse brain models of human diseases. Gene, Elsevier, 2016, 600, pp.90 - 100. ⟨10.1016/j.gene.2016.11.022⟩. ⟨hal-01433082⟩
  • Meryem Tardivel, Séverine Bégard, Luc Bousset, Simon Dujardin, Audrey Coens, et al.. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies. Acta Neuropathologica Communications, 2016, 4 (1), pp.117. ⟨10.1186/s40478-016-0386-4⟩. ⟨inserm-01391925⟩
  • Vânia Batalha, Diana Ferreira, Joana Coelho, Jorge Valadas, Rui Gomes, et al.. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports, Nature Publishing Group, 2016, 6 (1), ⟨10.1038/srep31493⟩. ⟨inserm-01833352⟩
  • Nicolas Barthélemy, Audrey Gabelle, Christophe Hirtz, François Fenaille, Nicolas Sergeant, et al.. Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies. Journal of Alzheimer's Disease, IOS Press, 2016, 51 (4), pp.1033 - 1043. ⟨10.3233/JAD-150962⟩. ⟨hal-01842422⟩
  • Vânia Batalha, Diana Ferreira, Joana Coelho, Jorge Valadas, Rui Gomes, et al.. mRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance. Journal of Molecular Neuroscience, Humana Press, 2016, 58 (4), pp.411-415. ⟨10.1007/s12031-015-0699-y⟩. ⟨hal-02541224⟩
  • Nicolas Barthélemy, François Fenaille, Christophe Hirtz, Nicolas Sergeant, Susanna Schraen-Maschke, et al.. Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity. Journal of Proteome Research, American Chemical Society, 2016, 15 (2), pp.667 - 676. ⟨10.1021/acs.jproteome.5b01001⟩. ⟨hal-01842426⟩
  • Anthony Papegaey, Sabiha Eddarkaoui, Vincent Deramecourt, Francisco-Jose Fernandez-Gomez, Pierre Pantano, et al.. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation. Acta Neuropathologica Communications, 2015, 4 (1), pp.74. ⟨10.1186/s40478-016-0345-0⟩. ⟨inserm-01346896⟩
  • Valeria Moas Heloire, Nicolas Renault, Vânia Batalha, Angela Rincon Arias, Mathieu Marchivie, et al.. Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolines. European Journal of Medicinal Chemistry, Elsevier, 2015, 106, pp.15-25. ⟨10.1016/j.ejmech.2015.10.030⟩. ⟨hal-02060788⟩
  • Dominique Caparros-Lefebvre, Lawrence Golbe, Vincent Deramecourt, Claude-Alain Maurage, Vincent Huin, et al.. A geographical cluster of progressive supranuclear palsy in northern France. Neurology, American Academy of Neurology, 2015, 85 (15), pp.1293-1300. ⟨10.1212/WNL.0000000000001997⟩. ⟨inserm-02460488⟩
  • Sophie Ayciriex, Marie-Anne Burlot, Jérome Braudeau, Kristin Michaelsen-Preusse, Brigitte Potier, et al.. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Human Molecular Genetics, Oxford University Press (OUP), 2015, 24 (21), pp.5965 - 5976. ⟨10.1093/hmg/ddv268⟩. ⟨hal-01779042⟩
  • Sara Kaffashian, Christophe Tzourio, Aïcha Soumaré, Carole Dufouil, Bernard Mazoyer, et al.. Association of plasma β-amyloid with MRI markers of structural brain aging the 3-City Dijon study.. Neurobiology of Aging, Elsevier, 2015, 36 (10), pp.2663-70. ⟨10.1016/j.neurobiolaging.2015.03.016⟩. ⟨hal-01197138⟩
  • Maxime Derisbourg, Coline Leghay, Giovanni Chiappetta, Francisco-Jose Fernandez-Gomez, Cyril Laurent, et al.. Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms. Scientific Reports, Nature Publishing Group, 2015, 5 (1), ⟨10.1038/srep09659⟩. ⟨hal-01659458⟩
  • Constance Delaby, Audrey Gabelle, Susanna Schraen-Maschke, Amandine Moulinier, Justine Boulanghien, et al.. Central Nervous System and Peripheral Inflammatory Processes in Alzheimer’s Disease: Biomarker Profiling Approach. Frontiers in Neurology, Frontiers, 2015, 6, ⟨10.3389/fneur.2015.00181⟩. ⟨hal-01842469⟩
  • Audrey Gabelle, Susanna Schraen, Laure-Anne Gutierrez, Cecile Pays, Olivier Rouaud, et al.. Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.. Alzheimer's and Dementia, Elsevier, 2015, 11 (6), pp.672-80. ⟨10.1016/j.jalz.2014.04.515⟩. ⟨inserm-01024830⟩
  • Julien Giustiniani, Kevin Guillemeau, Omar Dounane, Elodie Sardin, Isabelle Huvent, et al.. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior.. FASEB Journal, Federation of American Society of Experimental Biology, 2015, Epub ahead of print. ⟨hal-01145979⟩
  • Paul-Ariel Kenigsberg, Jean-Pierre Aquino, Alain Berard, Fabrice Gzil, Sandrine Andrieu, et al.. Dementia beyond 2025: knowledge and uncertainties. Dementia, SAGE Publications, 2015. ⟨hal-01850019⟩
  • Haoling Qi, François-Xavier Cantrelle, Houda Benhelli-Mokrani, Caroline Smet-Nocca, Luc Buée, et al.. Nuclear magnetic resonance spectroscopy characterization of interaction of Tau with DNA and its regulation by phosphorylation.. Biochemistry, American Chemical Society, 2015, 54 (7), pp.1525-33. ⟨hal-01145987⟩
  • Patricia Melnyk, Valérie Vingtdeux, Stéphane Burlet, Sabiha Eddarkaoui, Marie-Eve Grosjean, et al.. Chloroquine and Chloroquinoline Derivatives as Models for the Design of Modulators of Amyloid Peptide Precursor Metabolism. ACS Chemical Neuroscience, American Chemical Society (ACS), 2015, 6 (4), pp.559-569. ⟨10.1021/cn5003013⟩. ⟨hal-02060814⟩
  • Sara Kaffashian, Christophe Tzourio, Aïcha Soumaré, Carole Dufouil, Yicheng Zhu, et al.. Plasma β-amyloid and MRI markers of cerebral small vessel disease: Three-City Dijon study.. Neurology, American Academy of Neurology, 2014, 83 (22), pp.2038-45. ⟨10.1212/WNL.0000000000001038⟩. ⟨hal-01195583⟩
  • Amina Chaalal, Roseline Poirier, David Blum, Brigitte Gillet, Pascale Le Blanc, et al.. PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments.. Hippocampus, Wiley, 2014, 24 (11), pp.1381-93. ⟨10.1002/hipo.22319⟩. ⟨hal-01165538⟩
  • Simon Dujardin, Katia Lécolle, Raphaëlle Caillierez, Séverine Bégard, Nadège Zommer, et al.. Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: Relevance to sporadic tauopathies.. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2014, 2 (1), pp.14. ⟨10.1186/2051-5960-2-14⟩. ⟨inserm-00945726⟩
  • Simon Dujardin, Séverine Bégard, Raphaëlle Caillierez, Cédrick Lachaud, Lucie Delattre, et al.. Ectosomes: a new mechanism for non-exosomal secretion of tau protein.. PLoS ONE, Public Library of Science, 2013, 9 (6), pp.e100760. ⟨10.1371/journal.pone.0100760⟩. ⟨hal-01181185⟩
  • Kunie Ando, Pierre Dourlen, Anne-Véronique Sambo, Alexis Bretteville, Karim Bélarbi, et al.. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.. Neurobiol Aging, 2013, 34 (3), pp.757-69. ⟨10.1016/j.neurobiolaging.2012.08.004⟩. ⟨hal-00765859⟩
  • Oscar Hernández-Hernández, Céline Guiraud-Dogan, Géraldine Sicot, Aline Huguet, Sabrina Luilier, et al.. Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour.: Synaptic dysfunction in myotonic dystrophy. Brain - A Journal of Neurology , Oxford University Press (OUP), 2013, 136 (Pt 3), pp.957-70. ⟨10.1093/brain/aws367⟩. ⟨inserm-00795195⟩
  • Audrey Gabelle, Florence Richard, Laure-Anne Gutierrez, Susanna Schraen, Fleur Delva, et al.. Plasma Amyloid-β Levels and Prognosis in Incident Dementia Cases of the 3-City Study.: Plasma amyloid and prognosis in incident AD. Journal of Alzheimer's Disease, IOS Press, 2013, 33 (2), pp.381-91. ⟨10.3233/JAD-2012-121147⟩. ⟨inserm-00777823⟩
  • Jean-Charles Lambert, Benjamin Grenier-Boley, Denise Harold, Diana Zelenika, Vincent Chouraki, et al.. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease.. Molecular Psychiatry, Nature Publishing Group, 2012, 18, pp.521-521. ⟨10.1038/mp.2012.75⟩. ⟨hal-00778632⟩
  • Laëticia Troquier, Raphaëlle Caillierez, Sylvie Burnouf, Francisco Fernandez-Gomez, Marie-Eve Grosjean, et al.. Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.: Active Tau immunotherapy. Curr Alzheimer Res, 2012, 9 (4), pp.397-405. ⟨inserm-00664452⟩
  • C.M. Dhaenens, H. Tran, M.-L. Frandemiche, C. Carpentier, S. Schraen-Maschke, et al.. Mis-splicing of Tau exon 10 in myotonic dystrophy type I is reproduced by overexpression of CELF2 but not by MBNL1 silencing. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2011, ⟨10.1016/j.bbadis.2011.03.010⟩. ⟨hal-00694732⟩
  • Helene Tran, Nathalie Gourrier, Camille Lemercier-Neuillet, Claire-Marie Dhaenens, Audrey Vautrin, et al.. Analysis of Exonic Regions Involved in Nuclear Localization, Splicing Activity, and Dimerization of Muscleblind-like-1 Isoforms. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2011, 286 (18), pp.16435 - 16446. ⟨10.1074/jbc.M110.194928⟩. ⟨hal-01738403⟩
  • Catherine Féart, Catherine Helmer, Hervé Fleury, Yannick Béjot, Karen Ritchie, et al.. Association between IgM Anti-Herpes Simplex Virus and Plasma Amyloid-Beta Levels.. PLoS ONE, Public Library of Science, 2011, 6 (12), pp.e29480. ⟨10.1371/journal.pone.0029480⟩. ⟨inserm-00657059⟩
  • Isabelle Landrieu, Arnaud Leroy, Caroline Smet-Nocca, Isabelle Huvent, Laziza Amniai, et al.. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease.. Biochemical Society Transactions, Portland Press, 2010, 38 (4), pp.1006-11. ⟨10.1042/BST0381006⟩. ⟨hal-00586933⟩
  • Karim Belarbi, Katharina Schindowski, Sylvie Burnouf, Raphaëlle Caillierez, Marie-Eve Grosjean, et al.. Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease.. Current Alzheimer Research, Bentham Science Publishers, 2009, 6 (2), pp.152-7. ⟨inserm-00375282⟩
  • F. Checler, Luc Buée. [Fundamental data on the pathologies amyloid and Tau in Alzheimer's disease: which therapeutic perspectives?]. Annales Pharmaceutiques Françaises, Elsevier Masson, 2009, 67 (2), pp.136-53. ⟨10.1016/j.pharma.2009.01.002⟩. ⟨hal-00418765⟩
  • Susanna Schraen-Maschke, Nicolas Sergeant, Claire-Marie Dhaenens, Stephanie Bombois, Vincent Deramecourt, et al.. Tau as a biomarker of neurodegenerative diseases.. Biomarkers in Medicine, Future Medicine, 2008, 2 (4), pp.363-84. ⟨10.2217/17520363.2.4.363⟩. ⟨inserm-00375314⟩
  • C. M. Dhaenens, S. Schraen-Maschke, H. Tran, V. Vingtdeux, D. Ghanem, et al.. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.. Experimental Neurology, Elsevier, 2008, 210 (2), pp.467-78. ⟨10.1016/j.expneurol.2007.11.020⟩. ⟨hal-00282892⟩
  • Malika Hamdane, Pierre Dourlen, Alexis Bretteville, Anne-Véronique Sambo, Stéphanie Ferreira, et al.. Pin1 allows for differential Tau dephosphorylation in neuronal cells.. Molecular and Cellular Neuroscience, Elsevier, 2006, 32, pp.155-160. ⟨hal-00085645⟩
  • Isabelle Landrieu, Caroline Smet, Jean-Michel Wieruszeski, Anne-Véronique Sambo, René Wintjens, et al.. Exploring the Molecular Function of PIN1 by Nuclear Magnetic Resonance.. Current protein & peptide science, 2006, 7, pp.179-194. ⟨hal-00085621⟩
  • Guy Lippens, Alain Sillen, Caroline Smet, Jean-Michel Wieruszeski, Arnaud Leroy, et al.. Studying the natively unfolded neuronal Tau protein by solution NMR spectroscopy.. Protein and Peptide Letters, Bentham Science Publishers, 2006, 13, pp.235-246. ⟨hal-00085628⟩
  • Valérie Vingtdeux, Malika Hamdane, Marie Gompel, Severine Begard, Hervé Drobecq, et al.. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.. Neurobiology of Disease, Elsevier, 2005, 20, pp.625-37. ⟨hal-00098664⟩

Poster

  • Vincent Anquetil, Anne Bertrand, Agnès Camuzat, Pierre de La Grange, Clémence Fournier, et al.. Frontotemporal lobar degenerations, RNAopathy leading to proteinopathies. AAIC 2017 - Alzheimer's Association International Conference, Jul 2017, Londres, United Kingdom. 13 (7), 2017, ⟨10.1016/j.jalz.2017.06.1982⟩. ⟨hal-01672304⟩

Chapitre d'ouvrage

Rapport

  • Hélène Amieva, Sandrine Andrieu, Claudine Berr, Luc Buée, Frédéric Checler, et al.. Maladie d'Alzheimer : enjeux scientifiques, médicaux et sociétaux. [Rapport de recherche] Institut national de la santé et de la recherche médicale(INSERM). 2007, XV - 654 p., illustrations, figures. ⟨hal-01570630⟩